PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
1557611-2	1992	Interleukin-4 (IL-4) and interferon-gamma (IFN-gamma) decreased the level of ecto-5"-NT activity on BMC whereas prostaglandin E2 (PGE2) increased the ecto-5"-NT level.	Dinoprostone	112-128	5'-nucleotidase ecto	Homo sapiens	150-160	
1557611-2	1992	Interleukin-4 (IL-4) and interferon-gamma (IFN-gamma) decreased the level of ecto-5"-NT activity on BMC whereas prostaglandin E2 (PGE2) increased the ecto-5"-NT level.	Dinoprostone	130-134	5'-nucleotidase ecto	Homo sapiens	150-160	
1557611-9	1992	On BMC from 3 patients with hypogammaglobulinaemia, the effect of IL-4 on the level of ecto-5"-NT activity was identical to that found on BMC from healthy donors, whereas PGE2 increased ecto-5"-NT activity on BMC from only 1 of the 3 patients investigated.	Dinoprostone	171-175	5'-nucleotidase ecto	Homo sapiens	186-196	
28959385-8	2017	We identified exosomal prostaglandin E2 (PGE2) as a potential driver of CD73 induction, as inhibition of PGE2 receptors significantly reduced exosome-dependent CD73 induction.	Dinoprostone	23-39	5'-nucleotidase ecto	Homo sapiens	72-76	
28959385-8	2017	We identified exosomal prostaglandin E2 (PGE2) as a potential driver of CD73 induction, as inhibition of PGE2 receptors significantly reduced exosome-dependent CD73 induction.	Dinoprostone	41-45	5'-nucleotidase ecto	Homo sapiens	72-76	
28959385-8	2017	We identified exosomal prostaglandin E2 (PGE2) as a potential driver of CD73 induction, as inhibition of PGE2 receptors significantly reduced exosome-dependent CD73 induction.	Dinoprostone	41-45	5'-nucleotidase ecto	Homo sapiens	160-164	
32970317-0	2021	Enhanced migration of breast and lung cancer cells deficient for cN-II and CD73 via COX-2/PGE2/AKT axis regulation.	Dinoprostone	90-94	5'-nucleotidase ecto	Homo sapiens	75-79	
28959385-8	2017	We identified exosomal prostaglandin E2 (PGE2) as a potential driver of CD73 induction, as inhibition of PGE2 receptors significantly reduced exosome-dependent CD73 induction.	Dinoprostone	23-39	5'-nucleotidase ecto	Homo sapiens	160-164	
23619528-2	2013	Ectonucleotidases (CD39 and CD73)-generated extracellular adenosine and cyclooxygenase-2 (COX2)-derived prostaglandin E2 (PGE2) are amongst the tumor microenvironmental factors that have emerged as attractive targets in this regard.	Dinoprostone	104-120	5'-nucleotidase ecto	Homo sapiens	28-32	
28344879-7	2017	CD73 expression was inducible on CD14+ cells with sPE, cyclic-AMP (cAMP)-inducers (forskolin and prostaglandin-E2 (PGE2)) and adenosine.	Dinoprostone	97-113	5'-nucleotidase ecto	Homo sapiens	0-4	
28344879-7	2017	CD73 expression was inducible on CD14+ cells with sPE, cyclic-AMP (cAMP)-inducers (forskolin and prostaglandin-E2 (PGE2)) and adenosine.	Dinoprostone	115-119	5'-nucleotidase ecto	Homo sapiens	0-4	
28344879-12	2017	Taken together, CD73 expression can be induced by PGE2, cAMP or adenosine on human CD14+ cells.	Dinoprostone	50-54	5'-nucleotidase ecto	Homo sapiens	16-20	
23619528-2	2013	Ectonucleotidases (CD39 and CD73)-generated extracellular adenosine and cyclooxygenase-2 (COX2)-derived prostaglandin E2 (PGE2) are amongst the tumor microenvironmental factors that have emerged as attractive targets in this regard.	Dinoprostone	122-126	5'-nucleotidase ecto	Homo sapiens	28-32	
22146892-3	2012	These Treg express CD39 and up-regulate CD73 ectonucleotidases, hydrolyze exogenous adenosine triphosphate (ATP) to AMP and adenosine and produce prostaglandin E(2) (PGE(2)).	Dinoprostone	146-164	5'-nucleotidase ecto	Homo sapiens	40-44